Oral lecithin and linoleic acid in Friedreich's ataxia: I. Design of the study, material and methods.
A clinical and biochemical evaluation of twenty-two patients with Friedreich's Ataxia and ten normal controls was undertaken in 1980 to assess the effect of lecithin and linoleic acid supplements on the course of the disease. The trial consisted of two consecutive six months periods on either supplements in a double-blind crossover fashion. Clinical appraisal was performed with regards to the following parameters: joints mobility, muscle strength, equilibrium, coordination, motor accuracy, speech and numerous day to day activities. Blood samples were obtained at the beginning and in the course of the trial for enzymatic determinations. This paper describes the methodology of the study.
D000284:Administration, Oral; D000293:Adolescent; D000328:Adult; D002648:Child; D002986:Clinical Trials as Topic; D004311:Double-Blind Method; D005260:Female; D005621:Friedreich Ataxia / Q000188:drug therapy*; D006801:Humans; D019787:Linoleic Acid; D008041:Linoleic Acids / Q000627:therapeutic use*; D008124:Locomotion / Q000187:drug effects; D008297:Male; D009048:Motor Skills / Q000187:drug effects; D009119:Muscle Contraction / Q000187:drug effects; D010713:Phosphatidylcholines / Q000627:therapeutic use*
D008041:Linoleic Acids; D010713:Phosphatidylcholines; D019787:Linoleic Acid